Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.72

€4.72

2.550%
0.12
2.550%
-
 
31.05.24 / Tradegate WKN: A0BL84 / Name: Vita 34 / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Vita 34 AG Stock

Vita 34 AG gained 2.550% today.
Criterium "Business model" is seen as the biggest plus for Vita 34 AG stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Vita 34 AG in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Vita 34 AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Vita 34 AG 2.550% 1.724% -4.453% -31.792% -9.924% -69.548% -66.043%
Mediclin AG 3.450% -1.370% 2.128% -4.000% 8.271% -30.097% -45.660%
M1 Kliniken AG -2.820% -3.721% 52.206% 143.529% 86.486% 98.086% -
Capital Senior Living Corp. -1.650% -14.388% -19.048% 217.333% 175.145% -36.364% -57.233%

News

EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 returns to growth path in 2023
EQS-News: Vita 34 returns to growth path in 2023
EQS-News: Vita 34 returns to growth path in 2023
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures